• Delphia@lemmy.world
    link
    fedilink
    arrow-up
    11
    arrow-down
    1
    ·
    4 days ago

    I commented about this a while back and got shouted down.

    Theres a TON of promising compounds out there that dont get looked into by the drug companies because the process of developing a drug is so prohibitively expensive they are only interested in the patentable compounds that they can sell for mega dollars. It is POSSIBLE that a relaxation of some FDA rules might lead to some very interesting compounds finally getting some attention because they are finally cost effective to research.

    Look at bodybuilders and peptides, you cant patent most peptides because they are organic compounds which means no serious drug company is doing research on them and because no serious drug company is willing to put the money in they dont have FDA approval, and because they dont have FDA approval theres no guarantee that what your buying is actually what the label says or the concentration its supposed to be meaning any results attributed to them is dubious.

    • Mountainaire@lemmy.world
      link
      fedilink
      arrow-up
      6
      arrow-down
      1
      ·
      4 days ago

      and got shouted down.

      Well, they’re stupid, because you’re absolutely right. This is some fantastic stuff happening. 2026 is way too late, frankly, but better late than never!